Figure S4 from Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis Article Swipe
Related Concepts
Virotherapy
Oncolytic virus
Vaccinia
Peritoneal carcinomatosis
Virology
Virus
Medicine
Cancer research
Internal medicine
Biology
Cancer
Biochemistry
Colorectal cancer
Recombinant DNA
Gene
Ulrich M. Lauer
,
Martina Schell
,
Julia Beil
,
Susanne Berchtold
,
Ursula Koppenhöfer
,
Jörg Glatzle
,
Alfred Königsrainer
,
Robert Möhle
,
Dominik Nann
,
Falko Fend
,
Christina Pfannenberg
,
Michael Bitzer
,
Nisar P. Malek
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22470545
· OA: W4362406414
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22470545
· OA: W4362406414
<p>Comparison of 18F-FDG-PET-CT imaging pre-virotherapy versus day 24 post virotherapy.</p>
Related Topics
Finding more related topics…